Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

[Use of mesenchymal stemcells in dogs].

Meyer-Lindenberg A., Kilchling T.

Narrative Review on Osteoarthritis, published in Tierarztl Prax Ausg K Kleintiere Heimtiere (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Tierarztl Prax Ausg K Kleintiere Heimtiere (2018)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
30658370
DOI
10.1055/s-0038-1677407

Abstract (original English)

Mesenchymal stem cells (MSC) are multipotent cells, which are able to differentiate into various cell types of the body, as for example in osteogenic, chondrogenic, adipogenic and myogenic directions. In human medicine, the application of stem cells represents a well-established clinical procedure already applied for several decades. Addition-ally, in veterinary medicine, the stem-cell field is a rapidly growing sector for clinical use, particularly in horses. Recently, this treatment moda lity has also been commonly applied in dogs. The main field of application are diseases of the musculoskeletal system. Furthermore MSC are predominantly used for the treatment of lameness because of osteoarthritic changes of the large joints. In veterinary medicine, MSC are mainly isolated from bone marrow or adipose tissue. This artic le provides an overview of the removal site, isolation, characterisation and application of MSC. Moreover, studies available in the litera ture concerning the therapy of orthopaedic diseases in the dog using MSC are presented.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsDog DiseasesDogsMesenchymal Stem CellsOsteoarthritisStem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research